BDBM18517 6-(1-Pyrrolidine)quinolin-2(1H)-one, 4b(+/-)::6-(2-methylpyrrolidin-1-yl)-4-(trifluoromethyl)-1,2-dihydroquinolin-2-one::rac-6-(2-Methylpyrrolidin-1-yl)-4-trifluoromethyl-1H-quinolin-2-one
SMILES: CC1CCCN1c1ccc2[nH]c(=O)cc(c2c1)C(F)(F)F
InChI Key: InChIKey=MJCSHBNDRSZPKR-UHFFFAOYSA-N
Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kcal/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Androgen Receptor (Homo sapiens (Human)) | BDBM18517 (6-(1-Pyrrolidine)quinolin-2(1H)-one, 4b(+/-) | 6-(...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Patents Similars | Article PubMed | 72 | -10.1 | n/a | n/a | 13 | n/a | n/a | 7.4 | 37 |
Ligand Pharmaceuticals Inc. | Assay Description The compounds were evaluated in a transcriptional activation assay with hAR in a mammalian cell background (CV-1) as the primary in vitro assay. Rece... | J Med Chem 50: 5049-52 (2007) Article DOI: 10.1021/jm070231h BindingDB Entry DOI: 10.7270/Q29Z935Z | |||||||||||
More data for this Ligand-Target Pair |